3TC reverse transcriptase inhibitor: Will begin Phase II/III

The trials, using such surrogate markers as CD4 and p24 antigen, will compare 3TC alone and in combination with AZT, to AZT, or to AZT plus ddC. Similar applications have been made in Belgium, France...